Forecasts data is unavailable for this security.
Consensus recommendation
- 16-Nov-23
- 15-Aug-24
- 19-Sep-24
- 17-Oct-24
- 07-Nov-24
Select bar for recommendation details.
Recommendations | 07-Nov-24 | |
---|---|---|
Buy | 0 | |
Outperform | 2 | |
Hold | 6 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 7 analysts offering 12 month price targets for Recursion Pharmaceuticals Inc have a median target of 10.00, with a high estimate of 12.00 and a low estimate of 6.00. The median estimate represents a 31.93% increase from the last price of 7.58.
High | 58.3% | 12.00 |
Med | 31.9% | 10.00 |
Low | -20.8% | 6.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Feb 25, 2025.
Average growth rate | +5.48% |
Average growth rate | -3.73% |
More ▼
Revenue history & estimates in USD
Average growth rate | +28.87% |
Average growth rate | +151.67% |
More ▼